Eine rekombinante Produktionsplattform für Peptide
2021
The production of peptides as active pharmaceutical ingredients (APIs) by recombinant technologies is of emerging interest. A reliable production platform, however, is still missing due to inherent peptide characteristics such as proteolytic sensitivity, aggregation, and cytotoxicity. We developed a new approach — Numaswitch™. It solves present limitations and provides a cost-efficient production platform for diverse peptides and hard-to-be-expressed proteins.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
4
References
0
Citations
NaN
KQI